Transrectal ultrasound-guided prostate biopsy (TRBx) or transperineal Bx (TPBx) are considered alternative approaches for the diagnosis of prostate cancer (PCa). However, urinary tract infection (UTI) or other complications could be more frequent in the TRBx approach
To systematically review and meta-analyse available evidence comparing fosfomycin trometamol (FT) to...
Aim: To present our clinical experience about infective complications due to ultrasound guided trans...
PURPOSE: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may...
Our study aimed to compare the incidence of infective complications after transrectal ultrasound-gui...
Objective To compare fosfomycin trometamol (FT) and ciprofloxacin (CIP) for antibiotic prophylaxis ...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Objective: To compare, prospectively, 4 different schemes of antibiotic prophylaxis previ-ously to t...
Although the estimate of the incidence of sepsis following transrectal ultrasound-guided prostate bi...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
Background. Fluoroquinolone-resistant infections after transrectal prostate biopsy (TRPB) are increa...
Introduction: In this study, we aimed to identify risk factors for the development of infectious com...
Background: Transrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of the m...
Background: Fluoroquinolones are extensively used as prophylaxis for transrectal ultrasound-guided b...
BACKGROUND: Infection-related complications secondary to quinolone resistance have been on the rise ...
AbstractBackgroundTransrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of...
To systematically review and meta-analyse available evidence comparing fosfomycin trometamol (FT) to...
Aim: To present our clinical experience about infective complications due to ultrasound guided trans...
PURPOSE: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may...
Our study aimed to compare the incidence of infective complications after transrectal ultrasound-gui...
Objective To compare fosfomycin trometamol (FT) and ciprofloxacin (CIP) for antibiotic prophylaxis ...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Objective: To compare, prospectively, 4 different schemes of antibiotic prophylaxis previ-ously to t...
Although the estimate of the incidence of sepsis following transrectal ultrasound-guided prostate bi...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
Background. Fluoroquinolone-resistant infections after transrectal prostate biopsy (TRPB) are increa...
Introduction: In this study, we aimed to identify risk factors for the development of infectious com...
Background: Transrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of the m...
Background: Fluoroquinolones are extensively used as prophylaxis for transrectal ultrasound-guided b...
BACKGROUND: Infection-related complications secondary to quinolone resistance have been on the rise ...
AbstractBackgroundTransrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of...
To systematically review and meta-analyse available evidence comparing fosfomycin trometamol (FT) to...
Aim: To present our clinical experience about infective complications due to ultrasound guided trans...
PURPOSE: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may...